MCID: ALZ053
MIFTS: 20

Alzheimer Disease 7

Categories: Neuronal diseases, Rare diseases, Genetic diseases, Mental diseases

Aliases & Classifications for Alzheimer Disease 7

MalaCards integrated aliases for Alzheimer Disease 7:

Name: Alzheimer Disease 7 57 12 13 73
Ad7 57 12
Alzheimer Disease, Familial, 7 57
Alzheimer Disease, Familial 7 12
Alzheimer's Disease 7 12
Alzheimer Disease-7 57

Classifications:



External Ids:

OMIM 57 606187
Disease Ontology 12 DOID:0110039
ICD10 33 G30
MedGen 42 C1853555
UMLS 73 C1853555

Summaries for Alzheimer Disease 7

Disease Ontology : 12 An Alzheimer's disease that is characterized by an associated with variation in the region 10p13.

MalaCards based summary : Alzheimer Disease 7, also known as ad7, is related to alzheimer disease. An important gene associated with Alzheimer Disease 7 is AD7 (Alzheimer Disease 7). The drugs Aluminum hydroxide and Aluminum sulfate have been mentioned in the context of this disorder.

Description from OMIM: 606187

Related Diseases for Alzheimer Disease 7

Symptoms & Phenotypes for Alzheimer Disease 7

Clinical features from OMIM:

606187

Drugs & Therapeutics for Alzheimer Disease 7

Drugs for Alzheimer Disease 7 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 28)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aluminum hydroxide Approved, Investigational Phase 1, Phase 2 21645-51-2
2
Aluminum sulfate Approved Phase 1, Phase 2 10043-01-3
3
BCG vaccine Investigational Phase 1, Phase 2
4 Adjuvants, Immunologic Phase 1, Phase 2
5 Antacids Phase 1, Phase 2
6 Antibodies Phase 1, Phase 2
7 Antibodies, Anti-Idiotypic Phase 1, Phase 2
8 Antibodies, Monoclonal Phase 1, Phase 2
9 Anti-Ulcer Agents Phase 1, Phase 2
10 Gastrointestinal Agents Phase 1, Phase 2
11 Immunoglobulin Idiotypes Phase 1, Phase 2
12 Immunoglobulins Phase 1, Phase 2
13 Vaccines Phase 1, Phase 2
14 Cola Nutraceutical Phase 1, Phase 2
15
Dexamethasone Approved, Investigational, Vet_approved Phase 1 50-02-2 5743
16 Antiemetics Phase 1
17 Anti-Inflammatory Agents Phase 1
18 Antineoplastic Agents, Hormonal Phase 1
19 Autonomic Agents Phase 1
20 BB 1101 Phase 1
21 Dexamethasone acetate Phase 1 1177-87-3
22 glucocorticoids Phase 1
23 HIV Protease Inhibitors Phase 1
24 Hormone Antagonists Phase 1
25 Hormones Phase 1
26 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 1
27 Peripheral Nervous System Agents Phase 1
28
protease inhibitors Phase 1

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer Unknown status NCT00007826 Phase 1, Phase 2 alum adjuvant
2 RCT of IV Dexamethasone to Prevent Relapse in the Treatment of Migraine in a Paediatric ED Recruiting NCT02903680 Phase 1 Dexamethasone group;Placebo group
3 A Study to Assess the Safety, Pharmacodynamics, and Immunogenicity of PXVX0047 Terminated NCT03160339 Phase 1

Search NIH Clinical Center for Alzheimer Disease 7

Genetic Tests for Alzheimer Disease 7

Anatomical Context for Alzheimer Disease 7

Publications for Alzheimer Disease 7

Variations for Alzheimer Disease 7

Expression for Alzheimer Disease 7

Search GEO for disease gene expression data for Alzheimer Disease 7.

Pathways for Alzheimer Disease 7

GO Terms for Alzheimer Disease 7

Sources for Alzheimer Disease 7

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....